Comparison between the effect of L-propionylcarnitine, L-acetylcarnitine and nitroglycerin in chronic peripheral arterial disease: A haemodynamic double blind echo-Doppler study

C. Sabbá, E. Berardi, G. Antonica, G. Ferraioli, P. Buonamico, L. Godi, G. Brevetti, O. Albano

Research output: Contribution to journalArticlepeer-review

Abstract

The haemodynamic effects on the peripheral vascular bed of L-acetylcarnitine, L-propionylcarnitine, and nitroglycerin were tested by echo-Doppler in a double blind cross-over study. Eleven male patients suffering from peripheral arterial obliterative disease (PAOD) in the second stage of Fontaine's classification, and 11 matched control subjects were enrolled in the study. Each subject received one of three different treatments on each day of the study in a different order following a random assignment. The treatments were neither 30 mg x kg of L-acetylcarnitine (LAC) or 30 mg x kg of L-propionylcarnitine (LPC) or nitroglycerin (NTG) 1.25 mg given as a single i.v. bolus injected over 3 min. Echo-Doppler measurements of blood flow velocity, and cross-sectional area of the femoral artery were performed at baseline and 10, 20, and 30 min after injection of the drugs. Pulsatility Index (an index derived from the blood flow velocity and related to vascular resistance: PI = Vmax - Vmin/Vmean) was also obtained each time. Results were analysed using a Student's t-test for paired data. L-acetylcarnitine and L-propionylcarnitine showed no haemodynamic effects in either group of subjects (controls and PAOD patients) whether blood flow or vascular resistance was considered. There were haemodynamic changes (a decrease in blood flow velocity and an increase in arterial systemic resistance) only after NTG administration. The changes were more evident in controls than in PAOD patients. Femoral artery cross-sectional area showed no statistically significant effect as regards treatment. In conclusion, echo-Doppler flowmetry correctly assessed haemodynamic changes determined by the administration of NTG, whereas no changes were observed after LAC or LPC injection. Improvements in walking capacity after administration of these drugs could only be related to metabolic effects.

Original languageEnglish
Pages (from-to)1348-1352
Number of pages5
JournalEuropean Heart Journal
Volume15
Issue number10
Publication statusPublished - 1994

Keywords

  • L-carnitine
  • L-propionylcarnitine
  • Peripheral vascular disease
  • Walking capacity

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Statistics, Probability and Uncertainty
  • Applied Mathematics
  • Physiology (medical)
  • Physiology

Fingerprint Dive into the research topics of 'Comparison between the effect of L-propionylcarnitine, L-acetylcarnitine and nitroglycerin in chronic peripheral arterial disease: A haemodynamic double blind echo-Doppler study'. Together they form a unique fingerprint.

Cite this